Cord Blood Stem Cell TransplantationFetal BloodHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationMonocrotophosTransplantation, AutologousTransplantation, HomologousStem Cell TransplantationPenile ImplantationUmbilical CordStem CellsHematopoietic Stem CellsTransplantation ConditioningBlood BanksGraft vs Host DiseaseHematologic NeoplasmsAntigens, CD34Hematopoietic Stem Cell MobilizationBone Marrow TransplantationGranulocyte Colony-Stimulating FactorGraft SurvivalMelphalanLeukapheresisCell DifferentiationTreatment OutcomeCombined Modality TherapyTransplantation ChimeraBusulfanMyeloablative AgonistsCells, CulturedTissue DonorsSpinal CordMultiple MyelomaCyclophosphamideBlood Component RemovalMice, SCIDRecurrenceHistocompatibility TestingAntineoplastic Combined Chemotherapy ProtocolsRemission InductionWhole-Body IrradiationHistocompatibilityLiver TransplantationLeukemiaUmbilical VeinsImmunosuppressive AgentsRetrospective StudiesMesenchymal Stem Cell TransplantationTime FactorsLymphoma, Non-HodgkinHematopoiesisAntineoplastic Agents, AlkylatingVidarabineUmbilical ArteriesSpinal Cord InjuriesBlood CellsDisease-Free SurvivalGraft vs Leukemia EffectEtoposideInfectionSurvival RateThiotepaCell TransplantationSurvival AnalysisHematologic DiseasesLeukemia, Myeloid, AcuteSalvage TherapyTransplantation, IsogeneicEmbryonic Stem CellsKidney TransplantationPOEMS SyndromeAmyloidosisHLA AntigensHodgkin DiseaseFlow CytometryMice, Inbred NODAnemia, AplasticMyelodysplastic SyndromesT-LymphocytesMesenchymal Stromal CellsImmunophenotypingAdult Stem CellsFollow-Up StudiesLeukocytes, MononuclearCytomegalovirus InfectionsCytarabineAntigens, CDVincristineBlood Cell CountFatal OutcomeCell SeparationInfant, NewbornLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow CellsPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphomaCarmustinePregnancyLymphocyte DepletionBone Marrow